Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOBASE

The BIOBASE Group focuses on the development, production and management of scientific equipment, in vitro diagnosis (... read more Featured Products: More products

Download Mobile App





BIOBASE Showcases Comprehensive Range of Laboratory Solutions

By LabMedica International staff writers
Posted on 06 Feb 2025

BIOBASE (Shandong, China) is presenting its most popular laboratory products at Medlab Middle East 2025, including clinical chemistry, electrolyte and immunoassay analyzers. More...

The BK-410 automatic chemistry analyzer featured at the event is engineered to streamline laboratory workflows, providing reliable and precise results with unparalleled speed. Its comprehensive feature set makes it an invaluable asset for high-volume testing environments, ensuring accurate diagnostics and efficient laboratory operations. Featured alongside is the BKI1100 automatic chemiluminescence immunoassay system which uses magnetic particle separation technology for faster reaction speed and higher efficiency. BIOBASE is demonstrating the BK-EL10C ELISA microplate reader which uses enzyme-linked immunosorbent assay (ELISA) and other experimental methods to measure the absorbance and fluorescence intensity of reactants to quantitatively analyze specific components in samples.

BIOBASE is also showcasing the BKE-B electrolyte analyzer which adopts advanced ion-selective electrode measurement technology and is a fast, accurate, convenient, and practical clinical testing instrument. It can directly measure the concentration of K+, Na+, Cl-, Ca2+, and pH in serum, plasma, whole blood, cerebrospinal fluid, and diluted urine. In addition, BIOBASE is demonstrating the BKP2000 multi-channel dry fluorescence immunoassay analyzer with 12 independent incubation channels. The instrument comprises an optical detection module (fluorescence), scanning module, data processing module, liquid crystal display module, incubation module, information acquisition module (ID card reader), power supply, and printer. It also features automatic induction of reagent card insertion, automatic printing of test results, and automatic card loss along with a 10.1-inch LCD screen for a better visual experience.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Hematology Consumables
Bioblood Devices
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The integrated polygenic risk score combines information from multiple genetic variants into a single test that provides a result for each of eight cardiovascular conditions (photo credit: Adobe Stock)

Genomic Risk Score Identifies Inherited Risk for Multiple Cardiovascular Conditions

Cardiovascular disease is the leading cause of death worldwide, yet many at‑risk individuals are overlooked by traditional calculators. Tools that weigh age, sex, blood pressure, and cholesterol can miss... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.